Clinical Trial Update: Combination Immunotherapy in Rare Cancers Under InvesTigation [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update describing a combination immunotherapy study for rare cancers; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Female Reproductive System Neoplasms
• Msi-h Solid Malignant Tumor
• Neuroendocrine Tumors

Snippet

Sponsor: Olivia Newton-John Cancer Research Institute | Conditions: Advanced Biliary Tract Cancer, Neuroendocrine Tumors | Phase 2 | Status: ACTIVE_NOT_RECRUITING